Immutep Ltd (ASX: IMM)

Company Profile: Immutep Ltd (ASX: IMM) is a biotechnology company that has been working in the field of developing immunotherapy treatments for cancer and autoimmune diseases; and the group is now focused on leveraging its technology and expertise in bringing new and innovative treatments and solutions to the market for patients. IMM aims to provide good shareholder value through the development of its flagship products.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report